RJA
SGTX

Raymond James & Associates’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Raymond James & Associates’s Portfolio SGTX Stock Details SGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,723
Closed -$20.8K – 3947
2023
Q1 		$20.8K Buy
+1,723
New +$20.8K ﹤0.01% 3747